Professor Savulescu News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Should you be worried about the blood clot cases? After its official s remarks overnight about the casual link to very rare clotting, the EMA released a statement insisting its review into AstraZeneca was ongoing. Last week, it said it was yet to identify a link, nor any specific risk factors, such as gender, age or pre-existing medical conditions. Among the few dozen cases reported so far, most occurred in young and middle-aged women. That doesn t necessarily indicate the cohort is more at risk, though. Various theories are being explored by scientists, including that the AstraZeneca vaccine triggers an unusual antibody in some rare cases.

United kingdomMenaka paiMaureen ferranJulian savulescuMcmaster universityEuropean medicines agencyMurdoch children research instituteOxford universityRochester institute of technologyWorld health organisationFederal governmentRochester instituteMurdoch childrenResearch instituteProfessor savulescuஒன்றுபட்டது கிஂக்டம்